Entry Detail



General Information

Database ID:exR0371009
RNA Name:TKT
RNA Type:mRNA
Chromosome:chr3
Starnd:-
Coordinate:
Start Site(bp):53224712End Site(bp):53256052
External Links:ENSG00000163931



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCF1
chr6
30571393
30597179
+
AC104532.1
chr19
5904841
5914707
+
AC245033.1
chr15
82536788
82573194
-
AC124312.1
chr15
24955034
25000276
+
AC008982.1
chr19
38817471
38840178
-
ACTR1A
chr10
102461881
102502712
-
ALDOA
chr16
30064164
30070457
+
ACO2
chr22
41469117
41528989
+
ACAP1
chr17
7336529
7351477
+
ABCA2
chr9
137007234
137028922
-
AC104109.3
chr5
134167170
134226071
-
ACLY
chr17
41866917
41930542
-
AC004922.1
chr7
99325879
99394653
+
AC068580.4
chr11
1734821
1763954
-
AL136454.1
chr1
192716132
192716653
+
AD000671.2
chr19
35739252
35745432
-
AGO4
chr1
35808016
35857890
+
AC138969.1
chr16
16317444
16350590
+
ACTB
chr7
5527148
5563784
-
AC007192.1
chr19
18153158
18178117
+
ADAR
chr1
154582057
154628013
-
ACTG1
chr17
81509971
81523847
-
AKT1
chr14
104769349
104795751
-
AC010615.4
chr19
21405159
21491266
+
AC018523.2
chr11
14493783
14520344
-
AC004832.3
chr22
30409255
30428990
+
ADSL
chr22
40346500
40390463
+
AKAP12
chr6
151239967
151358559
+
AL022238.4
chr22
40346529
40410054
+
ADRM1
chr20
62302093
62308862
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC012236.1
chr15
31221999
31230838
-
AC087521.3
chr11
43921059
44001157
+
AC091564.7
chr11
6610883
6616594
-
AC091729.3
chr7
1160374
1165607
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL031282.2
chr1
1702736
1737688
-
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.